|
Sep 2025
As of Sep 30, 2025
|
Mar 2024
As of Mar 31, 2024
|
Dec 2023
As of Dec 31, 2023
|
Jun 2023
As of Jun 30, 2023
|
Dec 2022
As of Dec 31, 2022
|
Mar 2021
As of Mar 31, 2021
|
Dec 2020
As of Dec 31, 2020
|
Sep 2020
As of Sep 30, 2020
|
Jun 2020
As of Jun 30, 2020
|
Mar 2020
As of Mar 31, 2020
|
Dec 2019
As of Dec 31, 2019
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Current assets | |||||||||||
| Cash | |||||||||||
| Deposits | |||||||||||
| Deposits and prepaids | |||||||||||
| Prepaid consulting expense | |||||||||||
| Deposits and other prepaids | |||||||||||
| Total current assets | |||||||||||
| Property, plant and equipment, net | |||||||||||
| Right of use asset, net | |||||||||||
| Total Assets | |||||||||||
| Liabilities and Stockholders’ Deficit | |||||||||||
| Current liabilities | |||||||||||
| Accounts payable and accrued expenses | |||||||||||
| Deferred revenue | |||||||||||
| Convertible notes payable, related parties, net of discounts of $0 and $3,864, respectively | |||||||||||
| Convertible notes payable | |||||||||||
| Convertible notes payable, related parties | |||||||||||
| Convertible notes payable, in default | |||||||||||
| Convertible notes payable, in default - related parties | |||||||||||
| Notes payable, net of discount of $67,708 and $95,214, respectively | |||||||||||
| Notes payable | |||||||||||
| Notes payable, in default | |||||||||||
| Notes payable, in default - related parties | |||||||||||
| Line of credit | |||||||||||
| Shareholder loan | |||||||||||
| Operating lease liability, current | |||||||||||
| Finance lease liability, current | |||||||||||
| Total current liabilities | |||||||||||
| Operating lease liability, long term | |||||||||||
| Finance lease liability, long-term | |||||||||||
| Total Liabilities | |||||||||||
| Stockholders’ Deficit | |||||||||||
| Common stock, $0.0001 par value – 17,000,000,000 shares authorized; 9,751,711,188 and 8,944,932,833 shares issued and outstanding at September 30, 2025 and December 31, 2024, respectively | |||||||||||
| Common stock to be issued, $0.0001 par value, 38,373,211 and 33,039,877 shares outstanding at September 30, 2025 and December 31, 2024, respectively | |||||||||||
| Unearned compensation | |||||||||||
| Additional paid in capital | |||||||||||
| Accumulated deficit | |||||||||||
| Total Stockholders’ Deficit | |||||||||||
| Total Liabilities and Stockholders’ Deficit | |||||||||||
Loading...
